Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank71
3Y CAGR+3.9%
5Y CAGR+27.1%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+3.9%/yr
vs +8.8%/yr prior
5Y CAGR
+27.1%/yr
Recent deceleration
Acceleration
-4.9pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
3.3x
Strong expansion
Streak
2 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$13.58M+0.2%
2024$13.55M+16.2%
2023$11.66M-3.7%
2022$12.11M+23.4%
2021$9.82M+139.9%
2020$4.09M-75.2%
2019$16.50M+90.6%
2018$8.66M+46.1%
2017$5.93M-88.0%
2016$49.22M-